









시장가
/
주식
/
nasdaq-qtrx
/

Quanterix Corp

QTRX

6.090USD

+0.210+3.57%

종가 02/06, 16:00（ET）시세는 15분 지연됩니다

284.30M시가총액

손실P/E TTM



Quanterix Corp

6.090

+0.210+3.57%

개요 금융 분석 회사

개요

금융

분석

회사

자세한 내용은 Quanterix Corp 회사

Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.

Quanterix Corp 정보



종목 코드 QTRX

회사 이름Quanterix Corp

상장일Dec 07, 2017

CEOToloue (Masoud)

직원 수471

유형Ordinary Share

회계 연도 종료Dec 07

주소900 Middlesex Turnpike

도시BILLERICA

증권 거래소NASDAQ OMX - NASDAQ BASIC

국가United States of America

우편 번호01821

전화16173019400

웹사이트https://www.quanterix.com/

종목 코드 QTRX

상장일Dec 07, 2017

CEOToloue (Masoud)

Quanterix Corp의 회사 임원진



이름

이름/직위

직위

주식 보유

변동

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

282.30K

-1817.00%

Mr. William P. (Bill) Donnelly

Executive Chairman of the Board

140.51K

+2377.00%

Ms. Karen A. Flynn

Independent Director

49.78K

+23372.00%

Mr. Scott Mendel

Director

31.59K

+25316.00%

Dr. Myla P. Lai-Goldman, M.D.

Director

30.34K

+25316.00%

Mr. Jeffrey Thomas (Jeff) Elliott

Lead Independent Director

27.33K

+23372.00%

Ms. Vandana Sriram, CPA

Chief Financial Officer, Treasurer

9.95K

-4395.00%

Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.

Independent Director

Dr. Garret Hampton, Ph.D.

Independent Director

Dr. Alan Sachs, M.D., Ph.D.

Independent Director

이름

이름/직위

직위

주식 보유

변동

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

282.30K

-1817.00%

Mr. William P. (Bill) Donnelly

Executive Chairman of the Board

140.51K

+2377.00%

Ms. Karen A. Flynn

Independent Director

49.78K

+23372.00%

Mr. Scott Mendel

Director

31.59K

+25316.00%

Dr. Myla P. Lai-Goldman, M.D.

Director

30.34K

+25316.00%

Mr. Jeffrey Thomas (Jeff) Elliott

Lead Independent Director

27.33K

+23372.00%

수익 분석

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q2

FY2024Q1

FY2023

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

사업별USD

이름

수익

비율

Product revenue

26.15M

0.00%

Service and other revenue

13.95M

0.00%

Collaboration and license revenue

46.00K

0.00%

지역별USD

이름

수익

비율

North America

24.39M

0.00%

EMEA

11.08M

0.00%

Asia Pacific

4.68M

0.00%

사업별

지역별

사업별USD

이름

수익

비율

Product revenue

26.15M

0.00%

Service and other revenue

13.95M

0.00%

Collaboration and license revenue

46.00K

0.00%

주식 보유 통계

마지막 업데이트: Fri, Nov 21

주주

주주 유형

주주

비율

Portolan Capital Management, L.L.C.

9.12%

Columbia Threadneedle Investments (UK)

6.71%

BlackRock Institutional Trust Company, N.A.

6.12%

The Vanguard Group, Inc.

5.73%

Telegraph Hill Partners

5.36%

기타

66.95%

주주

비율

Portolan Capital Management, L.L.C.

9.12%

Columbia Threadneedle Investments (UK)

6.71%

BlackRock Institutional Trust Company, N.A.

6.12%

The Vanguard Group, Inc.

5.73%

Telegraph Hill Partners

5.36%

기타

66.95%

주주 유형

주주

비율

Investment Advisor/Hedge Fund

37.10%

Investment Advisor

22.29%

Hedge Fund

12.26%

Individual Investor

6.30%

Private Equity

5.36%

Research Firm

4.36%

Pension Fund

0.44%

Bank and Trust

0.20%

Family Office

0.13%

기타

11.56%

기관 주식 보유



마지막 업데이트: Thu, Jan 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q4

383

38.26M

81.91%

-7.44M

2025Q3

384

34.11M

73.41%

-9.53M

2025Q2

391

36.46M

81.18%

-12.95M

2025Q1

401

40.45M

104.19%

-6.42M

2024Q4

388

38.02M

98.63%

-6.28M

2024Q3

386

36.47M

95.03%

-5.94M

2024Q2

394

35.66M

93.20%

-9.57M

2024Q1

395

35.56M

93.43%

-9.17M

2023Q4

388

34.77M

91.99%

-10.35M

2023Q3

382

36.53M

97.35%

-9.84M

주주 활동



이름

보유 주식

비율

변동

Chg %

날짜

Portolan Capital Management, L.L.C.

4.26M

9.12%

+626.23K

+17.23%

Sep 30, 2025

Columbia Threadneedle Investments (UK)

3.14M

6.71%

+8.77K

+0.28%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

2.86M

6.12%

+212.22K

+8.01%

Sep 30, 2025

The Vanguard Group, Inc.

2.65M

5.67%

+118.56K

+4.69%

Sep 30, 2025

Telegraph Hill Partners

2.50M

5.36%

+2.50M

Sep 30, 2025

Walt (David R)

1.86M

3.99%

+2.59K

+0.14%

Oct 01, 2025

Invenomic Capital Management LP

1.39M

2.98%

+248.10K

+21.67%

Sep 30, 2025

William Blair Investment Management, LLC

1.32M

2.82%

+187.30K

+16.60%

Sep 30, 2025

Easterly Investment Partners LLC

1.25M

2.68%

+168.55K

+15.55%

Sep 30, 2025

Millennium Management LLC

1.21M

2.59%

+1.20M

+9880.18%

Sep 30, 2025

주식 배당금



지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.

날짜

배당금

기준일

지급일

배당락일

데이터 없음

주식 분할



날짜

배당락일

유형

비율

데이터 없음

날짜

배당락일

유형

비율

데이터 없음

KeyAI



Quanterix Corp

자세한 내용은 Quanterix Corp 회사

Quanterix Corp 정보

Quanterix Corp의 회사 임원진

수익 분석

주식 보유 통계

기관 주식 보유

주주 활동

관련 ETF

주식 배당금

주식 분할